Stocks · Health care · Pharmaceutical Preparations

Werewolf Therapeutics, Inc.

HOWL Clue Score19

United States Fiscal year ends December CIK 0001785530 Results filed 31 Jul 2026

Add to watchlist

By person

4 insiders · 139 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Luke Evnin

Director

—

$2.57M (79) scheduled

−$2.57M

0.0000%

$0.00

−100.0%

Ansbert Gadicke

Former 10% Owner

—

$1.16M (20) scheduled

−$1.16M

4,784,111

9.84%

$1.48M

−28.3%

MPM BioVentures 2014, L.P.

Former 10% Owner

—

$1.16M (20) scheduled

−$1.16M

4,784,111

9.84%

$1.48M

−28.6%

Ra Capital Management, L.p. entity

10% owner

—

$963.93K (20)

−$963.93K

303,719

0.6249%

$94.15K

−83.8%

Werewolf Therapeutics, Inc.

What the insiders did Net selling

By person